Activation of transcription factors by extracellular nucleotides in immune and related cell types
Open Access
- 3 January 2007
- journal article
- review article
- Published by Springer Nature in Purinergic Signalling
- Vol. 3 (1-2) , 59-69
- https://doi.org/10.1007/s11302-006-9037-8
Abstract
Extracellular nucleotides, acting through P2 receptors, can regulate gene expression via intracellular signaling pathways that control the activity of transcription factors. Relatively little is known about the activation of transcription factors by nucleotides in immune cells. The NF-κB family of transcription factors is critical for many immune and inflammatory responses. Nucleotides released from damaged or stressed cells can act alone through certain P2 receptors to alter NF-κB activity or they can enhance responses induced by pathogen-associated molecules such as LPS. Nucleotides have also been shown to regulate the activity of other transcription factors (AP-1, NFAT, CREB and STAT) in immune and related cell types. Here, we provide an overview of transcription factors shown to be activated by nucleotides in immune cells, and describe what is known about their mechanisms of activation and potential functions. Furthermore, we propose areas for future work in this new and expanding field.Keywords
This publication has 54 references indexed in Scilit:
- Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expressionNeurochemistry International, 2006
- TLR signalingCell Death & Differentiation, 2006
- Purinergic mechanism in the immune system: A signal of danger for dendritic cellsPurinergic Signalling, 2005
- Protein-DNA Array-based Identification of Transcription Factor Activities Regulated by Interaction with the Glucocorticoid ReceptorPublished by Elsevier ,2004
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBαMolecular and Cellular Biology, 2001
- P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug developmentDrug Development Research, 2000
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Apoptosis in bone physiology and disease.Molecular Pathology, 1997
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997